Have your press releases posted here?
- Cytotoxics remain standard bearers
- The Board of International Biotechnology Trust Plc (“IBT”) today announces its unaudited Annual Results for the twelve months ended 31 August 2005
- MOUSE GENES OFF THE SHELF Geneservice and RZPD to distribute DNABookTM
- York Pharma founds Japanese operating company and appoints President
- Epitan Completes Recruitment and Dosing for Photoprotection Trial in Sydney
- IMMUTEP Appoints Michel Greco To Board Of Directors
- SR Pharma: Interim results for the six months ended 30 June 2005
- Pioneer of drug discovery data management software recognized for his contribution to the industry
- IDBS launches ActivityBase XE – revolutionary solution for high throughput screening data management
- Apollo grows with acquisition
- $60 billion of pharmaceutical company revenues under threat from generic drugs
- LifePharms, Inc. Receives Approval for Phase II SBIR Grant for Cancer Research from NIH
- Lipoxen announces collaboration agreements with Baxter Healthcare & two other biopharmaceutical companies
- Epitan begins PMLE trial in Melbourne
- Singvax And Octoplus Announce Collaboration To Develop Single-Shot Japanese Encephalitis Vaccine
- CellCentric and Cancer Research Technology initiate co-development partnership
- GM food avoidance policies to become more expensive, according to new report
- RNTECH & DNAVision Announce A Co-Marketing Agreement To Offer A Complete Solution For Biomarker And Target Discovery In Oncology
- York Pharma appoints new Chairman
- Launch of East Midlands bioscience knowledge exchange initiative
- Millipore and Oxford Immunotec Co-develop Plates for Diagnosing and Monitoring Infections
- G-BOX, a New Concept in Image Analysers Offers the World’s First Affordable Custom Designed System
- Cytheris launches a new Phase I clinical trial in the US for its recombinant Interleukin-7
- DE NOVO LAUNCHES REFLEX, A MAJOR UPGRADE TO ITS IN SILICO DRUG DESIGN PLATFORM
- Novagali Pharma completes a Phase I clinical trial in oncology with its oral formulation of Paclitaxel
- Eyes turning to Neuropathic pain market
- New Order for Biacore®A100 Received from Major Pharmaceutical Company
- ViRexx completes $4 million private placement
- Phase I ProCord Study Results Published in the Journal of Neurosurgery: Spine September 2005 Issue
- Agilent Technologies launches ChIP-on-chip microarray platform, enabling researchers to analyze gene regulation
- Drug Safety in the Post-Vioxx Era
- Antibacterial hope lies in clever drugs for superbugs
- M&A is not the only way
- Merck & Co - Amrad: an uncertain pathway to success
- Doubling up in battle to beat cholesterol
- Epitan receives ethics approval for Phase II PMLE trial at St Vincent's Hospital in Melbourne
- New vaccine offers better protection against pulmonary tuberculosis
- Bayer Selects InforSense for Next Generation Integrative Analytics Infrastructure - InforSense KDE to Provide Workflow-based Cheminformatics Platform
- P2i plan to extend pipette nano-coating success to other consumables and devices - Saving the very last drop
- Protagen AG - Powerful protein biochips for antibody development
- Liponex Develops Improved Formulation of CRD5
- Oxford Biomedica Announces Appointment Of Chief Medical Officer
- Solexa And Collaborating Scientists Illuminate The Small RNA Component Of The Transcriptome
- BioPlanta GmbH and AnalytiCon Discovery GmbH announce their cooperation in the plant-based search for active ingredients
- Dnavision Is The First European Pharmacogenomic Service Laboratory To Succeed Iso/Iec 17025 Audit
- Northbank Communications strengthens team with two new staff additions
- CellCentric receives new funding from NESTA to further its work in epigenetics and cancer
- Innate Pharma obtains ISO9001:2000 certification for its research and development activity in the field of immunotherapy
- Evolva Acquires Pharmaceutical Business of Poalis
- York Pharma founds UK commercial operations unit and appoints Sales & Marketing Director
- BioPortfolio BioNewsCast Client Press Releases 2005 Archive
- BioPortfolio BioNews (News & Press Releases) August 2005
- BioPortfolio BioNews (News & Press Releases) July 2005
- BioPortfolio BioNews (News & Press Releases) June 2005
- BioPortfolio BioNews (News & Press Releases) May 2005
- BioPortfolio BioNews (News & Press Releases) April 2005
- BioPortfolio BioNews (News & Press Releases) March 2005
- BioPortfolio BioNews (News & Press Releases) February 2005
- Psoriasis: Biologics hope to reach 8mill undiagnosed sufferers
- Blockbuster brands generate generic goals
- Cobra signs long term deal with Neovacs SA to supply Phase I clinical trial material for a novel protein active immunization therapy-TNFa Kinoid
- Dr. Steven St. Peter Joins Atugen’s Supervisory Board
- SYMPHOGEN STRENGTHENS PATENT POSITION IN POLYCLONAL ANTIBODIES
- NextGen Sciences receives the Frost & Sullivan Technology Leadership Award for 2005
- BioCentral Investors’ Day - Unique growth opportunities for venture capital investors
- ROLF STAHEL APPOINTED AS CHAIRMAN OF POWDERMED
- MNLpharma Strengthens Team
- Emerging treatments for inflammatory bowel disease
- Migraine treatment - a financial headache
- New trial of HIV/AIDS vaccine incorporates Cobra technology
- OXFORD BIOMEDICA AND VIRAGEN REPORT PROGRESS IN AVIAN TRANSGENICS BIOMANUFACTURING
- Sigma-Aldrich to Acquire Proligo Group to Strengthen Genomics Research Tools Portfolio
- Trends in drug patent expirations - new features from thinkPharm
- Top 7 Reasons To Attend IBC’s IBC’s Regulatory Submission Standards Conference
- Grant Instruments - for precision temperature control you can rely on
- Analytical Method Validation Case Studies of Practical Solutions for Various Assay Types and Stages of Drug Development
- InterMune's hepatitis strategy gets the right response
- Innovatives & supportive care way forward for Cancer drugs
- New ChemiGeniusXE 3 The Highest Resolution Multi-Purpose Image Analyser Available
- JPK Instruments AG - More space for Nanobiotechnology
- Sigma-Aldrich Offers Instant Savings with Its New Lab Start-Up Program
- BioImpact: Biotechnology for patients
- Industrialists call for a real industrial and financial policy for biotechnologies in Europe
- A Possible Mechanism for the "Broken Heart" Syndrome
- Q Chip - Microfluidics Venture Motors Ahead
- CATACHEM, INC. is pleased to announce the addition of Fructosamine (glycated proteins) to the DiscretePak™ and VetSpec™ line of diagnostic chemistry reagents.
- CATACHEM, INC. tiene el gusto de anunciar la adición de fructosamina (proteínas glucadas) a la línea de los reactivos químicos clínicos de diagnostico, DiscretePak™ y VetSpec™.
- Catachem is pleased to announce the availability of our VetSpec™ diagnostic test reagents for the COBAS MIRA™, discrete, random access analyzer.
- Catachem se siente muy contenta de anunciar la disponibilidad de sus reactivos de diagnóstico DiscretePak™
- New Web Site for Microscopists Offers Simple Guide to Tools for Improving Digital Imaging
- Cobra extends its agreement with Oncolytics Biotech Inc. to provide long term manufacture of REOLYSIN®
- BIO Deutschland Calls on Amendment of the Stem-Cell Act Stem Cells: Yes to Research, but no Therapy?
- How Employers and Commercial Landlords Can Maintain a Mold-Safe Workplace
- ATUGEN AND ASINEX ANNOUNCE DISCOVERY PROGRAM FOR NOVEL PROTEIN KINASE TARGET
- CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) GROUP PLC
- Progress in the treatment of peripheral arterial disease (PAD)
- Eisai's retinoic acid (RAR)-alpha receptor agonist as a candidate therapy for the treatment of lupus nephritis
- Asthma: alternative anti-inflammatory agents needed for patient subgroup
- Biacore launches new generation system for protein interaction analysis
- ExonHit Launches SpliceArray Service With GPCR And Ion Channel Microarrays Using Agilent Technologies' Microarray Platform
- Genetix launches breakthrough technology for the development of biopharmaceuticals
- OXFORD BIOMEDICA SIGNS LENTIVECTOR® LICENSING AGREEMENT
- New Agonist Antagonist Optimal Ratio Combinations as a Potentially Safer Class of Pharmaceutical Drugs
- The Overlooked Problem of Drug-Receptor Desensitization
- Screen Validates MNLpharma’s Compound Activity
- HIV vaccines: education key to partial efficacy success
- Migraine treatment financial headache for national healthcare systems
- Biomedical Photometrics Launches TISSUEscope
- SYMPHOGEN A/S NAMED BY TORNADO INSIDER AMONG EUROPE'S TOP 100 PRIVATE TECH COMPANIES
- CATACHEM, INC. announces the addition of Fructosamine (glycated proteins) to the DiscretePak™ and VetSpec™ line of diagnostic chemistry reagents
- Catachem announces availability of VetSpec™ diagnostic test products
- NEURO3d NAMED BY TORNADO INSIDER AMONG EUROPE’S TOP 100 PRIVATE TECH COMPANIES
- IntegraGen to take a leading role in unraveling the genetics of obesity in a €14.5M EU funded program
- Professor Cy Stein Joins Atugen’s Scientific Advisory Board
- Chronic hepatitis B and C: a chronic lack of effective treatment
- Strategic alliances – what’s the big deal?
- New Application of ChemiGenius2 To Analyse Large Proteins Associated with Type 2 Diabetes
- ESBATech hires CFO and Director of Preclinical Development
- New Ant Species Identified by Harvard University Using Syncroscopy’s Auto-Montage Software
- SyncroScan Improves Imaging of Human Hip Bones At Major European Bone Research Unit
- Incomplete control of HbA1c levels is the major drawback to current non-insulin antidiabetics
- Oxford Immunotec Appoints Stuart Rose as Global Marketing Director
- Genetix Limited launches QPExpression – new automated bacterial protein expression system
- Agilent Technologies Expands Custom Microarray Offering with Industry's First Shared-Design Program
- Malvern launches new web resource for protein researchers
- SCYNEXIS Europe appoints Geoffrey Sheppard as Head of Radiochemistry
- Scancell Signs New Agreement with Biovation to DeImmunise SC101
- Details of £4.3 million Agreement Announced on 22 September 2004 Partner : Serono - Human Growth Hormone : Drug for Needle-free System
- 'Silent killer' osteoporosis quietly on the increase
- TiGenix completes recruitment of multinational Phase III clinical trial for cartilage repair
- Shantha Biotech Introduces Shanvac-B in BD Uniject™
- SENEXIS APPOINTS CHRIS MOYSES AS CHAIRMAN AND DAVID SCOPES AS CHIEF SCIENTIFIC OFFICER
- Morphochem enters Research Alliance with Alcon to develop novel ophthalmic compounds
- Paradigm Therapeutics Ltd acquires Amedis Pharmaceuticals Ltd
- SOCS1 silencing dramatically increases the anti-cancer efficacy of dendritic cell vaccines
- Agilent Technologies Expands Microarray Platform to Address New Array-Based Genomics, Disease Research Applications
- Agilent Technologies Acquires Computational Biology Corp., Pioneer in Gene Regulation Analysis
- Agilent Technologies Announces Breakthrough for Cancer Researchers Studying Chromosomal Changes
- DOW PHARMACEUTICAL SCIENCES ACQUIRES BIOSKIN, EUROPE’S LEADING DERMATOLOGY CRO
- OXFORD BIOMEDICA SIGNS LENTIVECTOR® LICENSING AGREEMENT WITH BIOGEN IDEC
- Sorafenib offers hope in the battle for liver cancer survival
- IntegraChips™ to help develop “identity cards” for cancer tumours
- Peakdale Molecular appoints Glenn Killingworth to strengthen US Sales
- OXFORD BIOMEDICA PUBLISHES PRECLINICAL EFFICACY RESULTS WITH ITS PRODUCT CANDIDATE SMN1-G FOR SPINAL MUSCULAR ATROPHY
- $42.6 Million Five-Year Grant From Gates Foundation for Antimalarial Drug Brings Together Unique Collaboration of Biotech, Academia and Nonprofit Pharma
- BioPortfolio BioNews (News & Press Releases) January 2005
- BioPortfolio BioNewsCast Client Press Releases 2004 Archive
- BioPortfolio BioNews (News & Press Releases) December 2004
- BioPortfolio BioNews (News & Press Releases) November 2004
- BioPortfolio BioNews (News & Press Releases) October 2004
- RNAi therapeutics company atugen receives Frost & Sullivan Award
- POTENT PRECLINICAL EFFECT OF NOVEL MELANOMA PEPTIDE VACCINE REPORTED AT THE SEVENTH INTERNATIONAL ANTICANCER CONFERENCE IN CORFU, GREECE
- Generex Biotechnology introduces Glucose Spray; First Product of the Diabetes Management System to reach the market
- Nonlinear Dynamics and GenoLogics Life Sciences Software announce partnership for integrated protein informatics solution
- SYMPHOGEN ANNOUNCES USD 25 MILLION FINANCING FROM INTERNATIONAL INVESTORS
- DR. DAVID OSBORNE, VP PRODUCT DEVELOPMENT AT DOW PHARMACEUTICAL SCIENCES, SPEAKS AT SOCIETY FOR INVESTIGATIVE DERMATOLOGY COURSE IN PHILADELPHIA
- Agilent Technologies Completes Acquisition of Silicon Genetics, Leading Provider of Life Science Informatics
- BIO Deutschland: Independent Biotechnology Industry Organisation Founded
- Tipranavir submission takes fight to HIV mutations
- Proteom and 14TM announce a strategic partnership in GPCR ligand design
- OXFORD BIOMEDICA AND ARIUS RESEARCH EXTEND COLLABORATION ON NOVEL CANCER TARGETS
- Sentrx Announces Reseller Agreement with Zenosis Limited Coincides with the Release of Zenosis Pharmacovigilance Modules
- MorphoSys Reports third quarter 2004 results. Company expects to obtain profitablity by 2005
- Internationals Flock to see Best of Australian Biotech
- Ashlee Simpson - Too Young for Acid Reflux? - No - millions of children and teens have it
- Nonlinear Dynamics Appoints Elchrom Scientific as TotalLab Distributor
- First Annual RNAi Europe Conference and Exhibition - A Major Success
- DRI launches high sensitivity RNA purification products based on ChargeSwitch technology
- siFECTamineT is superior to in vitro market leader says new Biochemistry paper
- BioPortfolio Bulletin - CNS Disorders markets, news, links and reports
- Cardiovascular risks of HRT confirmed
- ADHD children not coming to attention of Drs
- Petra Biotek Announce the Availability of Technology Designed to Optimize Dose Modification, Accelerate Drug Development and to Limit Failure of Phase I and II Clinical Trials
- An introduction to the key CNS Disorders
- BioPartners Submits an Application for Approval of the First Biosimilar Recombinant Interferon alpha for Hepatitis C in Europe
- Visions of Biotechnology - a Community Forum into 2020
- Best of Biotechnology on Show in Brisbane
- The CNS Market Outlook to 2009
- The Cancer Market Outlook to 2009
- The Cardiovascular Market Outlook to 2009
- PARI Aerosol Research Institute’s Formulation Work and eFlow Featured in Corus Pharma’s Positive Phase II Trial Results
- Nonlinear Dynamics announce listings in Deloitte Fast 50 and Sunday Times Tech Track 100
- ASINEX LTD. AND RECORDATI S.P.A. ANNOUNCE AN INTEGRATED DRUG DISCOVERY PROJECT
- ASINEX and SIENABIOTECH announce Lead Generation Collaboration
- COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact
- Flu season begins but a vaccine shortage awaits
- Nonlinear Dynamics announces another year of record figures
- Liponex announces U.S. patent and trial results for drug that boosts good cholesterol
- GM crop opponents’ theory on co-existence “exaggerated”
- New Automated Colony Counter Used to Detect a Range of Diverse Bacteria at Major Food Testing Centre
- Agilent Technologies' New Spin Cartridges Remove High-Abundance Proteins from Blood Serum Using Benchtop Centrifuge
- Human Genome Pioneer Joins AusBiotech 2004 - Unravelling the Genetic Code of Australia’s Biodiversity
- Umicore to manufacture product for Oxonica's photostable OPTISOLT UV Absorber
- TxCell raises EUR10.5 million Series A to finance phase I-IIA clinical trials
- Sigma Partners with Ingex on Targeted Gene Disruption Technology
- Sirenade announces breakthrough in the development of Tau-Directed theraputics for Alzheimer's
- PowderMed initiates a phase I clinical trial for a therapeutic Herpes Simplex type 2 vaccine
- GENEREX BIOTECHNOLOGY PRESENTS INFORMATION AT THE EUROCONFERENCE VACCINES 3 MEETING OF THE PASTEUR INSTITUTE IN PARIS ON THE USE OF NOVEL PEPTIDE VACCINE FOR MELANOMA
- GENOME express launches Gextrack, for food identification through DNA analysis
- Cambridge Healthtech Institute - Licensing and Partner Congress
- Emma Palmer appointed as Associate Director, head of Financial PR/IR
- Life after Vioxx - $2.5 billion up for grabs?
- HIV infection - changes in epidemiology driving R&D development and increased market value
- Dr. Eric von Hofe appointed Generex VP for Product Development & Scientific Affairs
- Icoria, Inc. Expands Partnership with Agilent Technologies to Include $11.7 Million ATP Grant for Informatics
- Entomed appoints Dr. Yves Ribeill to its board of directors
- Agilent Technologies Donates Microarrays to Vanderbilt University for Courses in Genomic Technologies, Bioinformatics
- Therapeutic activity of Bayer's BAY 43-9006 in renal cell carcinoma
- Osteoarthritis treatment and markets post VIOXX - reports, news, opinions
- Validated blood tests provide new alternative to liver biopsy for assessing status of liver disease in hepatitis C patients
- Agilent Technologies Announces More Than One Million Bioanalyzer Chips Sold
- Generex Biotechnology Corporation Oral-lyn™, the Company’s proprietary oral insulin spray formulation, and its RapidMist™ Diabetes
- Sigma-Aldrich and Rubicon Genomics announce GenomePlexT Whole Genome Amplification Licensing Agreement
- Atlas Venture and Global Life Science Ventures invest in Nitec Pharma AG
- Asthma Control and Asthma Impact Surveys Launched by QualityMetric
- NextGen Sciences Ltd introduces a new suite of revolutionary tools for molecular biology and protein research
- Cobra Biomanufacturing appoints Cathy Smith to strengthen North America Sales
- New molecular target identified for the prevention of Alzheimer's disease
- BioPortfolio BioNews (News & Press Releases) September 2004
- BioPortfolio BioNews (News & Press Releases) August 2004
- Pharmacological activation of transforming growth factor-beta1 (TGF-beta1) may be of benefit as a stroke prevention stategy
- Effect of CytoregR on Biomarkers in B16-F10 Murine Melanoma
- Clinical data further demonstrates the efficacy of Pfizer's pregabalin (Lyrica) in the treatment of diabetic neuropathic pain
- BioPortfolio BioNews and BioWatch - comprehensive news and email alerts services for the life sciences
- Agilent Technologies Increases Investment in Rosetta Biosoftware's Life Science Informatics
- Agilent Technologies to Acquire Silicon Genetics, Leading Provider of Life Science Informatics
- PARI Granted Orphan Drug Designation for Inhaled Cyclosporine – Potential New Therapy for Lung Transplant Patients
- Bionest Partners appoints Advisory Board
- Low level carbon monoxide exposure as a therapeutic approach to improving transplant outcome
- Evolva raises € 12 million A-round from International Investors
- Institute for OneWorld Health to Compile Comprehensive State of Infectious Diarrhea Treatments and Potential Solutions
- Vernalis extends cancer research collaboration with Novartis Institutes for BioMedical Research
- Cobra authorised to manufacture broad range of biopharmaceuticals for European Clinical trials
- Nonlinear Dynamics and Matrix Science Integrate Leading Proteomics Software Products
- UPDATE - It's not just drug discovery that's an expensive business
- UPDATE - DNA Research Innovations publishes its new expanded range of CST products in a new catalogue
- UPDATE - Images of World’s Largest Rotifer Reference Collection Captured on CD in less than Three Months by Auto-Montage
- UPDATE Building Biotechnology - Starting, managing, and understanding biotechnology companies' is a comprehensive resource on commercializing biotechnology
- Clinical data supports the development of insulin as a future treatment for memory and mood disorders?
- New TB test brings tuberculosis care into 21st century
- New rhinitis therapy should help patients to breathe easy
- Building Biotechnology - Starting, managing, and understanding biotechnology companies' is a comprehensive resource on commercializing biotechnology
- Images of World’s Largest Rotifer Reference Collection Captured on CD in less than Three Months by Auto-Montage
- DNA Research Innovations publishes its new expanded range of CST products in a new catalogue
- It's not just drug discovery that's an expensive business
- Peakdale and Cyprotex collaborate on drug-like screening compounds
- Innate Pharma raises 15 million euros in intermediate financing round
- Big bucks battling super bugs?
- Dowpharma sharpens focus on new expression systems; closes site
- THE WERCS CONTINUES TO EXPAND Company Adds Two Industry Veterans to Business Development Team
- PRODUCERS OF DRUG DISCOVERY TECHNOLOGY® WORLD CONGRESS ANNOUNCE 2nd ANNUAL ASIA PACIFIC EVENT
- Capsulution NanoScience AG Positive Half-Year Results Following Significant Rise in Turnover
- Lord Sainsbury, UK Minister for Science and Innovation, Opens the New Sigma-Genosys Oligonucleotide Production Site, in Haverhill, UK
- IntegraGen appoints Steve Lombardi as non-executive director
- Syngene - University of Cambridge Installs Innovative Imaging System To Save Time with Important Research on Plant Growth
- GENOME express and Institut Pasteur sign partnership agreement
- Nonlinear Dynamics and LifeGels Ltd (Previously Gradipore Ltd) Enter Progressive Distribution Agreement
- UPDATE - Peakdale launches 2nd GPCR targeted library ahead of plan
- UPDATE - QualityMetric announces royalty-free access to DYNHA® for scholarly research
- UPDATE - PROLYSIS ANNOUNCES APPOINTMENT OF PROFESSOR ROGER FINCH TO SCIENTIFIC ADVISORY BOARD
- UPDATE - GM planting regime: report of the Environment, Food & Rural Affairs Committee ignores important evidence submitted to it
- BioPortfolio BioNews (News & Press Releases) July 2004
- DNA Research Innovations launches GeneCatcher
- AnalytiCon Discovery: Discovery and Development of New Classes of Anti-Cancer-Drugs
- Grant BTD - round, rapid, reliable heating
- HomelandDefenseStocks.com Reports on The Security Implications of AIDS
- GM planting regime: report of the Environment, Food & Rural Affairs Committee ignores important evidence submitted to it
- PROLYSIS ANNOUNCES APPOINTMENT OF PROFESSOR ROGER FINCH TO SCIENTIFIC ADVISORY BOARD
- QualityMetric announces royalty-free access to DYNHA® for scholarly research
- Peakdale launches 2nd GPCR targeted library ahead of plan
- Pharmaceutical companies set to make a significant profit from anti-obesity drugs
- Agilent Technologies Introduces Qualification Service for GCs' Heated Zones
- Roche's Fuzeon offers hope...to the 20% of patients that receive it
- Agilent Technologies Gains Exclusive Rights to Sell SSI's CyberLAB Enterprise Content Management System
- What’s new at BIOPHEX2004?
- Life Sciences Day of DVC Deutsche Venture Capital – Highlights and Trends in the Biotechnology-Sector in Germany
- New Automated System for Microscopes Offers High-speed Slide Scanning to Create Precise Image Maps
- AnalytiCon Discovery: Successful collaboration with Kyowa Hakko
- Vernalis plc and Endo Pharmaceuticals Holdings Inc. Announce North American Licence Agreement and Co-Promotion Option for Frova™
- BioPortfolio Bulletin - Bioterrorism, Anthrax, Smaalpox, Vaccines, New Reports
- Scancell Company Profile
- OneWorld Health to Work with Sanaria Inc. on Novel Malaria Vaccine Approach
- Advances in the development of corticotropin-releasing-hormone (CRH) receptor agonists as candidate analgesics
- Agilent Technologies Introduces Proteomics Product to Remove High-Abundance Proteins from Mouse Blood Serum
- Prolysis Company Profile
- No recovery in Pharmaceutical Fine Chemicals market until 2005
- DVC Deutsche Venture Capital achieves a substantial return on the asset sale of portfolio company Probiodrug to Prosidion Ltd.
- Morphochem appoints Sijmen de Vries as CEO
- The emerging role of the IL-4/IL-3 cytokine receptor IL-4Ralpha in asthma
- Haptogen granted European patent for it’s DBDx™ display technology
- Strong potential for cross risk-factor single pill therapies
- PHARMACEUTICAL COMPANIES SET TO MAKE A SIGNIFICANT PROFIT
- Tissue Microarrays : Market Assessment and Opportunities
- RNAi the hottest technology in drug discovery
- Proteomics market shows rapid growth
- Eden Biopharma Group raises £5million in investment
- André Pernet joins Bionest Partners as associate member
- National Biomanufacturing Centre paves the way for European Biotech Success
- BioPortfolio Bulletin - Life Science directories, Protein Crystallography, Directory of Molecular Diversity Suppliers, Tissue Microarrays
- Avidis names new CEO and management committee members
- OXFORD BIOMEDICA LICENSES LENTIVECTOR TECHNOLOGY TO VIRAGEN FOR AVIAN TRANSGENICS BIOMANUFACTURING
- atugen and Eisai Sign First Contract Research Agreement
- Early adopters of ePrescribing serve as models in a growing market
- METABOLIC SYNDROME REACHES EPIDEMIC LEVEL
- BioPortfolio BioNews (News & Press Releases) June 2004
- BioPortfolio BioNews (News & Press Releases) May 2004
- Archemix Presents at Friedman, Billings, Ramsey Investor Conference
- British biotechnology company Ardana Ltd. attracts DVC Deutsche Venture Capital as new investor
- Landmark new study identifies successful management practices in Biotech companies
- Takeda makes strategic investment in Lectus Therapeutics
- BioPortfolio: BIOPHEX 2004, ViroPharm Auction, BioNews, Aging Population eport Offers
- TekCel News: Introducing Adaptive Process TechnologyT
- Nano-biotechnological Applications Excellently Positioned on the Asian Market
- UK scientists pioneer novel treatment for motor neuron disease
- Genomatix Corporation, a genetic materials manufacturer, has relocated its operations to Roanoke and Blacksburg, Virginia
- Lilly's pemetrexed (Alimta) offers potential improvements in the treatment of non-small cell lung cancer (NSCLC)
- Maternal screening for hypothyroidism and hypothroxinemia
- KORN/FERRY INTERNATIONAL announces the appointment of Jacques Police Senior Client Partner, Global Life Sciences Group
- BioPortfolio: BPS Launches - Biomanufacturing & Biologics Clinical Trails Databases
- New Possibilities in Living Cell Microscopy JPK extends the NanoWizard® AFM System with BioCell(TM)
- Korn/Ferry International Announces The Appointment Of Jacques Police
- Institute for OneWorld Health Completes Patient Enrollment, Treatment In India for Largest Phase III Clinical Trial for Visceral Leishmaniasis (Kala Azar)
- Agilent Technologies Wins Decision on AP-MALDI Patent
- Agilent Technologies' New Protein Identification System Helps Biomedical Researchers Identify More Proteins with Greater Confidence
- Vernalis plc: Board changes
- Hybrigenics and Shanghai Institute of Materia Medica announce screening and discovery collaboration
- Inpharmatica signs PharmaCarta[TM] discovery collaboration with Procter & Gamble
- The BIOPHEX 2004 Conference, presented by Genetic Engineering News, helps put your products on the fast track to commercialization
- GM and non GM arable crops can co-exist in the EU without problems: says new research paper
- Syngene - New Application for ChemiGenius Offers Inexpensive Method of Analysing Proteomics Gels
- Pharma companies must implement initiatives to improve core drug discovery capabilities
- DEVELOGEN COMPLETES 19 MILLION EURO FINANCING ROUND
- PowderMed launched in spin out of powder injection DNA vaccine programmes from Chiron vaccines
- atugen and Sankyo Sign Multi-Year Contract Research Agreement
- New Microscopy Software from Synbiosis Accurately Counts Thousands of Cells in an Instant
- New Products to Improve Microscope Images On Stand G3 at MicroScience 2004
- Northbank Communications Strengthens PR Team with the Appointment of Dr Douglas Pretsell as Account Manager
- NicOx's nitro-derivative of naproxen, HCT 3012, shown to be effective in a model of myocardial infarction
- BioPortfolio: Biotech Pharma Auction, Pain Special, Growthink Healthcare Venture Report
- RZPD's Affymetrix Service - Faster Detection of Genetic Variations in Humans
- atugen AG demonstrates in vivo proof-of-concept in siRNA therapeutics
- Results from the PACES trials provides further good news for Pfizer's Celebrex (celecoxib)
- Gabapentin as a first line treatment of spinal cord injury-related
- Morphochem AG Announces First Closing of its 15 Million Euros ($18.5 Million) Financing Round
- Oxagen Announces the Appointment of David U'Prichard as Non-Executive Chairman
- Roche pipeline to fuel future growth
- Aptanomics and Nanosyn collaborate to discover new cancer drugs
- New data reveals that the calcium channel blocker ethosuximide is an effective treatment of cancer pain
- R&D innovations to drive growth in osteoporosis market
- BioPortfolio: CNS resources, CANTAB Cognitive Assessment, Biotech Insight, DailyUpdates, Growthink Healthcare Venture Report
- Cancer treatment pioneer Scancell moves base to BioCity
- International patent granted to Capsulution NanoScience AG covering the manufacture of novel nano- and micro-capsules
- BioPortfolio BioNews (News & Press Releases) April 2004
- BioPortfolio BioNews (News & Press Releases) March 2004
- Agilent Technologies Introduces Ion Trap Mass Spectrometer with 4x Improvement in Sensitivity
- Biotech Tracker: SGN-40 for Multiple Myeloma
- Vernalis plc: preliminary results for the eight months ended 31 December 2003
- Vernalis regains control of North American rights to frovatriptan from Elan
- DailyUpdates - breaking journal and press release articles for the drug development sector
- Syncroscopy - New 3-D Imaging Software Makes Leading Technology Affordable for All Microscopists
- Merck & Co develop new leads for the treatment of bipolar disorder through the development of a new HTS assay of inositol monophosphatase inhibitors
- SWITCH Biotech AG Joint Forces Against Vitiligo
- ASINEX and SIENABIOTECH announce Lead Generation Collaboration
- Sulfonylureas vs thiazolidinediones for the prevention of diabetic nephropathy
- Cytomyx Licenses Cancer Database To Astrazeneca
- Frank Morich joins Innate Pharma's board of directors
- Biotech Tracker: Antibody Drugs from PDLI Advance
- Biotech Tracker: Gene Therapy Trial for Rheumatoid Arthritis Underway
- New data published on KW-7158, a novel treatment of overactive bladder
- Inpharmatica Announces Biopendium Online [TM] Subscription Agreement with Taisho of Japan
- Oxford Biomedica awarded £0.5 million from the UK department of health gene therapy research programme
- NMDA receptor antagonism limits visceral hypersensitivity and may offer an approach to functional gut disorders
- Shire Pharmaceuticals boosted by first Fosrenol approval
- MUNICH BIOTECH REPORTS ADDITIONAL POSITIVE DATA FROM MBT- 0206 PHASE I TRIAL
- NextGen Sciences announces distribution agreement with SCRUM Inc. in Japan
- Lynx and Solexa Jointly Acquire DNA Technology Assets
- Researchers report the efficacy of the bisphosphonate, YM529 in preclinical rheumatoid arthritis studies
- Agilent Technologies Upgrades Software for Mass Spectrometry-Based Proteomics Research
- Researchers report that controlling intracellular calcium levels may offer a new dual approach to hypertension and diabetes
- CHI's Portfolio Management, Project Management, Strategic Planning, Drug Discovery R&D and Knowledge Management
- Biotech Tracker: Orphan for Exelixis
- Biotech Tracker: Zenapax (Daclizumab) for Asthma
- Beta-O2 completes $2 million seed round led by Vitalife
- New research supports switching from to exemestane after two to three years of tamoxifen therapy in women with primary breast cancer
- Siegfried delivers solid results
- Syngene - New Imaging System has World Premier On Syngene Stand 461 at Analytica
- Inpharmatica announces ADME technology agreement with GlaxoSmithKline
- Capsulution NanoScience AG Diagnostic Particle Expert Appointed to Advisory Board
- New Medical Director at SOLVO Biotechnology
- Bionest Partners appoints senior consultant in corporate finance and strategic consulting
- Boehringer Ingelheim Researchers develop new therapeutics for the treatment of chronic hepatitis C infection
- DNA Research Innovation Ltd. Announces OEM Agreement with Isohelix Ltd
- Biotech Tracker: Riquent Still Has Hurdles to Overcome
- Biotech Tracker: E.U. to Review Inhaled Insulin Approval Application
- Cytokine targeting of dendritic cells to tumors produces dramatic anti-cancer activity
- Respiratory Syncytial Virus: Can antivirals make the grade?
- DVC Deutsche Venture Capital strengthens its management team in the technology field
- AMT Amsterdam Molecular Therapeutics (AMT) Obtains Orphan Drug Designation for its LPL Gene Therapy Product
- Potential of ghrelin receptor ligands in the treatment of cardiovascular disease
- New Contract Research Organization (CRO) Special Report Reveals 10 Ways To Make Better Hires Faster
- GANYMED Pharmaceuticals AG and the University of Rotterdam Establish new Cooperation
- Biotech Tracker: TKT’s I2S Trial Moving Forward
- Biotech Tracker: Risk of Adversities with Stem Cells Therapy in the Heart
- Granulocyte colony-stimulating factor (G-CSF) as a new therapeutic approach to myocardial infarction.
- Synbiosis: New Motorised Stage for Automated Zone Reader - Guarantees Rapid Analysis of Bioassay Plates
- Enhanced Epilepsy Therapy with Genetic Analysis
- COBRA SIGNS AGREEMENT TO MANUFACTURE AVIDEX' FIRST MONOCLONAL T CELL RECEPTORS
- Neuropathic Pain: Pfizer attempting to hold on to market leadership
- Yale researchers discover a role for Kv1.3 potassium channels in the etiology of diabetes as well as obesity
- Syngene - New Chemiluminescence Image Analyser Guarantees High Resolution for Greater Accuracy
- Biotech Tracker: Revlimid Orphaned Again
- NextGen Sciences attracts new investors and builds its Board of Directors
- OSI pharmaceuticals report on the pharmacokinetics, safety and efficacy of their anticancer thymidylate synthase inhibitor, OSI-7904L
- Comments on GM Foods: evaluating the Farm Scale Trials: report of the Environmental Audit Committee of 2 March 2004
- PIPELINE 2004: PORTFOLIO STRATEGY CONGRESS FEATURES TOP 25 PHARMA, BIOTECHS, WALL STREET AND VENTURE CAPITAL THROUGH 4 TRACKS AND 80+ SPEAKERS
- Flinder Medical Centre researchers discover the cause of diabetic gastrointestinal dysfunction
- GM CROP TRIALS COULD POSE THREAT TO LAND VALUES
- abc welcomes Government approval of GM crops
- Overexpression of malonyl-coenzyme A (CoA) decarboxylase as a novel therapeutic approach to insulin resistance
- Agilent Technologies Announces 50,000th Shipment of Its Industry-Leading Liquid Chromatography System
- Cambridge Consultants - Encouraging Signs in UK Technology Markets
- Global Life Science Ventures announces investment into CareX
- New data confirm that Fujisawa Pharmaceuticals' poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor FR255595 limits neural damage in models of Parkinson's disease
- BioTech Stock Report: An Ounce of Prevention - Vaccines
- GREENPEACE AND MILK - THE FACTS on GM Animal Feed
- Biotech Tracker: Inhaled Cystic Fibrosis Therapy Data Encouraging
- Biotech Tracker: SGN-30 is an Orphan, but May Lose Out to Sister Construct
- Fungal infections: From specialty area to expanded population
- Adiponectin limits tumor angiogenesis-the missing link between obesity and increased risk of developing cancer?
- JPK Instruments Opens Door to Japanese Market Distribution Agreement Signed With the TOYO Corporation
- Agilent Technologies Combines Gene Expression, Proteomics and Reagents Businesses into New Life-Sciences Unit
- Agilent Technologies Introduces LC System for Proteomics that Combines Micro Collection and Spotting Capabilities
- BioPortfolio: BioOncology 2004, European Hospital Register, 2:1 Job Adverts
- Oxford Biomedica Plc: Preliminary Results For The Year Ended 31 December 2003
- Japanese researchers identify Interleukin-5 (IL-5) receptors as a target for preventing airway remodelling in asthma
- Biotech Tracker: Thalomid: What’s in a Label?
- Biotech Tracker: Neuroimmunophilin Ligands Still Need to Demonstrate Therapeutic Effect
- SCYNEXIS signs a drug discovery deal with Mitsubishi Pharma
- Oxxon Pharmaccines Appoints Frank Malinoski MD PhD as Chief Medical Officer
- Biotech Tracker: Phenoptin Trial Underway
- Biotech Tracker: Setback for Cortex’s Ampakine Program
- University of Texas Medical Branch researchers publish key data on respiratory syncytial virus infection
- Richard A. Lerner, M.D., President Of The Scripps Research Institute, To Lead Dyadic Scientific Advisory Board
- Montalier International Ltd., a leading international partnering consultancy and conference acquires Tri-Med Pharmaceuticals
- HRT declared unsuitable for first line osteoporosis prevention
- Inpharmatica selects MDL to distribute Biopendium worldwide
- Veteran Executive Richard Soltero To Head PharmaDirections
- BioPortfolio BioNews (News & Press Releases) Febuary 2004
- BioPortfolio BioNews (News & Press Releases) January 2004
|
